Microbial sciences company Seed Health closed a $40 million Series A financing round and Dutch company Anavo Therapeutics announced seed financing totaling €20 million ($24 million) to discover small molecules that target phosphatases.
If you are not happy with the results below please do another search
50 search results for:
The European Commission is working on legal proceedings against AstraZeneca after the drugmaker cut Covid-19 vaccine deliveries to the European Union, sources familiar with the matter said.
India recorded the world’s highest daily tally of 314,835 Covid-19 infections on April 22 as a second wave of the pandemic raised new fears about the ability of crumbling health services to cope.
Technical experts at the World Health Organization (WHO) will review on April 26 Chinese drugmaker Sinopharm’s Covid-19 vaccine for possible emergency use listing, to be followed by the Sinovac jab on May 3, the agency said on April 22.
In a move to help underserved women join the workforce and to strengthen the impact of its employee volunteer efforts, The Bloc joined the business community of Working for Women (W4W).
Bausch Health Companies and Ortho Dermatologics announced statistically significant topline results from a second pivotal Phase 3 clinical trial evaluating the investigational medicine IDP-126, a combination retinoid, anti-bacterial and antibiotic topical to treat acne vulgaris in patients 9 years of age and older.
Roche culled two more Phase II Covid-19 programs, as announced in the Swiss pharma giant’s first-quarter 2021 financial report.
FCB Health Network president & CEO Dana Maiman on April 21 announced Debra Polkes joined FCBCURE as creative partner and co-managing director. Reporting to Maiman, Polkes will work closely with FCBCURE’s managing director, Tammy Fischer, to continue to drive the momentum and growth of the agency, and take the creative department to even greater heights.
Johnson & Johnson is establishing a vaccine supply network in which 10 manufacturing sites would be involved in the production of the company’s Covid-19 vaccine, in addition to J&J’s plant in Leiden, the Netherlands.
As we continue to sift through the barrage of information regarding survival rates, resurgence, vaccines, and secondary illnesses, COVID-19 and its economic impact continues to a primary global burden. In the midst of those serious concerns, the health and life sciences (HLS) industry continues its accelerated journey of perpetual assessment and evolution. As the industry emerges from the pandemic effect, leaders are realizing that COVID-19 has provided crucial learnings to their organizations that will benefit the entire industry, according to Astound Commerce’s Tina Wilson.